DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prothionamide
Prothionamide
Para-Aminosalicylic Acid – Biopharmaceutical, Pharmacological
TB Policies in 24 Countries a Survey of Diagnostic and Treatment Practices About Médecins Sans Frontières
Treatment of Tuberculosis in Pregnant Women and Newborn Infants
Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R
MDR-TB): Evidence and Perspectives
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Clinical Implications of the Global Multidrug-Resistant Tuberculosis Epidemic
Efficacy and Tolerability of Ethionamide Versus Prothionamide: a Systematic Review
Supplementary Tables
(12) United States Patent (10) Patent No.: US 7,504,381 B2 Mor Et Al
Antimicrobial Resistance in Bacteria
Drug-Resistant Tuberculosis 2020: Where We Stand
Visão De Futuro Para Produção De Antibióticos: Tendências De Pesquisa, Desenvolvimento E Inovação
DR-TB DRUGS UNDER the MICROSCOPE Sources and Prices for Drug-Resistant Tuberculosis Medicines 2Nd Edition – November 2012
Mechanisms of Drug Resistance in Mycobacterium Tuberculosis: Update 2015
WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment
Host-Directed Therapeutics As a Novel Approach for Tuberculosis Treatment Ye-Ram Kim1,2 and Chul-Su Yang1,2*
Treatment of MDRTB
Top View
Public Assessment Report
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
The Future of Drug-Resistant Tuberculosis Treatment: Learning from the Past and the 2019 World Health Organization Consolidated Guidelines
Enges in Low- and Middle-Income Populations
Pharmacokinetics and Dosing Rationale of Para
Higlance Catelouge 2014.Pdf
Granupas, INN-Para-Aminosalicylic Acid
Laws of Brunei Chapter 114 Poisons
Lack of Evidence to Support Policy Development for Management of Contacts of Multidrug-Resistant Tuberculosis Patients: Two Systematic Reviews
Handbook of Anti-Tuberculosis Agents
Antituberculotics and Antileprotics ●Tuberulosis (Consumption; TBC) – WHO Report: 2.109 Infected in 2009 ●Leprosy (Hansen Disese, Hanseniasis) – Approx
Annual Report 2018 Tuberculosis & Chest
A Clinical Trial of Ethionamide and Prothionamide for Treatment of Lepromatous Leprosy
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Prothionamide
An Activist's Guide to Tuberculosis Drugs 2016 Update
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Administration of a Bowel Cleanser and an Antibiotic for the Treatment of Bowel Disease
Terizidone J04ak03
Supplementary Materials for Table of Contents PICO Questions
The Shorter MDR-TB Regimen BACKGROUND (In Addition, Ethiopia, Mongolia, South Africa and Viet Nam
Annual Report 2015 Tuberculosis & Chest Service of the Department Of
Pharmacokinetics of Prothionamide in Patients with Multidrug-Resistant Tuberculosis
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
ICD-10-CM Table of Drugs 2019
International Classification of Procedures in Medicine
Mutation Etha Confers Co-Resistance to Prothionamide and Ethionamide In
Drug-Resistant Tuberculosis: a Survival Guide for Clinicians
Data Sheet of Clinical Trial C.T
Belgian Journal of Paediatrics
Second-Line Antituberculosis Drugs in Children